We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




World’s Smallest Single-Chamber MR Conditional Pacemaker Streamlines MRI Workflow

By MedImaging International staff writers
Posted on 07 Jul 2023
Print article
Image: Amvia Edge is the market\'s smallest single-chamber MR conditional pacemaker (Photo courtesy of BIOTRONIK)
Image: Amvia Edge is the market\'s smallest single-chamber MR conditional pacemaker (Photo courtesy of BIOTRONIK)

Historically, individuals with a pacemaker, implantable cardioverter-defibrillator (ICD), or cardiac resynchronization therapy (CRT) device were unable to undergo magnetic resonance imaging (MRI) due to these devices' lack of approval for MRI scanning and the untested effects of MRI on ICDs. A new generation of pacemakers now integrates an always-on, automatic MR detection algorithm to significantly streamline the MRI workflow.

BIOTRONIK’s (Berlin, Germany) portfolio of Amvia Edge line of pacemakers and CRT pacemakers marks its latest innovation in cardiac rhythm management. The Amvia Edge, the smallest single-chamber MR conditional pacemaker available, combines patient-centric clinical solutions with automated workflow efficiency. The device integrates BIOTRONIK's unique MRI Guard 24/7 technology, which utilizes always-on, dedicated sensors that automatically detect the patient's entry into an MRI field, subsequently switching the device to MRI mode. Once the scan is complete, the device reverts to its original programming, eliminating the need for pre- or post-scan programming.

Additionally, all Amvia Edge devices incorporate Atrial ATP (aATP), offering multiple automatic therapies in response to stable atrial arrhythmias. This feature could reduce the burden of atrial tachycardia and help prevent atrial remodeling. Atrial tachycardia can increase the risk of stroke and heart failure, consequently reducing the quality of life. Alongside its MRI and atrial arrhythmia solutions, Amvia Edge introduces new tools that automate key tasks, such as pre-discharge checks. The EarlyCheck feature allows a device report and IEGM to be automatically dispatched to the Home Monitoring Service Center two hours post-implant, eliminating the requirement for in-person device interrogation. BIOTRONIK's Amvia Edge pacemakers and CRT-P portfolio has been approved by the U.S. Food and Drug Administration (FDA).

"MRI Guard 24/7 is a solution for real-world challenges, as we strive to improve safety and increase efficiencies for CIED patients who need MRI access," said Dr. David Hayes, Chief Medical Officer, BIOTRONIK, Inc. "An MRI scan should be as easy as possible for patients, but also for caregivers in the device clinic and the MRI suite. MRI Guard 24/7 avoids repeat visits to the clinic for pre- and post-programming, and because the device only switches to MRI mode during the scan itself, it minimizes any potential patient discomfort."

"Amvia Edge represents BIOTRONIK's continued commitment to healthcare professionals to help them serve their patients," said Ryan Walters, President, BIOTRONIK, Inc. "The clinical treatment options and built-in efficiencies of Amvia are designed to solve everyday challenges for patients, physicians, and caregivers."

Related Links:
BIOTRONIK 

New
Leg Wraps
Leg Wraps
New
MRI Infusion Workstation
BeneFusion MRI Station
New
Cylindrical Water Scanning System
SunSCAN 3D
New
Biopsy Software
Affirm® Contrast

Print article

Channels

MRI

view channel
Image: An AI tool has shown tremendous promise for predicting relapse of pediatric brain cancer (Photo courtesy of 123RF)

AI Tool Predicts Relapse of Pediatric Brain Cancer from Brain MRI Scans

Many pediatric gliomas are treatable with surgery alone, but relapses can be catastrophic. Predicting which patients are at risk for recurrence remains challenging, leading to frequent follow-ups with... Read more

Nuclear Medicine

view channel
Image: In vivo imaging of U-87 MG xenograft model with varying mass doses of 89Zr-labeled KLG-3 or isotype control (Photo courtesy of L Gajecki et al.; doi.org/10.2967/jnumed.124.268762)

Novel Radiolabeled Antibody Improves Diagnosis and Treatment of Solid Tumors

Interleukin-13 receptor α-2 (IL13Rα2) is a cell surface receptor commonly found in solid tumors such as glioblastoma, melanoma, and breast cancer. It is minimally expressed in normal tissues, making it... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.